You are here:

maraviroc (Celsentri)

Advice

in the absence of a submission from the holder of the marketing authorisation:

maraviroc (Celsentri®) is not recommended for use within NHS Scotland.

Indication under review: In combination with other antiretroviral medicinal products for treatment-experienced adolescents and children of 2 years and older and weighing at least 10kg infected with only CCR5-tropic HIV-1 detectable.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: maraviroc (Celsentri)
SMC Drug ID: 1282/17
Manufacturer: ViiV Healthcare/GSK
Indication: In combination with other antiretroviral medicinal products for treatment-experienced adolescents and children of 2 years and older and weighing at least 10kg infected with only CCR5-tropic HIV-1 detectable.
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 9 October 2017

Back